Chemoinformaics analysis of Pandamarilactone 32
| Molecular Weight | 299.37 | nRot | 4 |
| Heavy Atom Molecular Weight | 278.202 | nRig | 17 |
| Exact Molecular Weight | 299.152 | nRing | 3 |
| Solubility: LogS | -3.459 | nHRing | 2 |
| Solubility: LogP | 3.513 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 43 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 21 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 47.5687 |
| nHD | 0 | BPOL | 26.2493 |
| QED | 0.923 |
| Synth | 3.564 |
| Natural Product Likeliness | 0.775 |
| NR-PPAR-gamma | 0.114 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.224 |
| Pgp-sub | 0.002 |
| HIA | 0.023 |
| CACO-2 | -4.775 |
| MDCK | 0.0000249 |
| BBB | 0.025 |
| PPB | 0.972513 |
| VDSS | 0.796 |
| FU | 0.0263222 |
| CYP1A2-inh | 0.582 |
| CYP1A2-sub | 0.934 |
| CYP2c19-inh | 0.266 |
| CYP2c19-sub | 0.139 |
| CYP2c9-inh | 0.496 |
| CYP2c9-sub | 0.594 |
| CYP2d6-inh | 0.814 |
| CYP2d6-sub | 0.886 |
| CYP3a4-inh | 0.031 |
| CYP3a4-sub | 0.217 |
| CL | 8.319 |
| T12 | 0.795 |
| hERG | 0.047 |
| Ames | 0.016 |
| ROA | 0.247 |
| SkinSen | 0.952 |
| Carcinogencity | 0.914 |
| EI | 0.025 |
| Respiratory | 0.829 |
| NR-Aromatase | 0.817 |
| Antiviral | Yes |
| Prediction | 0.808452 |